Fermenta Biotech Ltd
Fermenta Biotech Ltd (FERMENTA) last reported results for the quarter ended Jun 2026, with sales of ₹122 crore and net profit of ₹9.53 crore. Fermenta Biotech Ltd’s board meets on 14 Oct 2026. The stock last traded at ₹518, a market capitalisation of ₹1,528 crore, on a P/E of 27.9. Over the past 52 weeks the stock has ranged between ₹249 and ₹583. Figures are as of 9 Oct 2026 and are not real time.
Fermenta Biotech Ltd share price and key metrics
- Current price
- ₹518
- Market cap
- ₹1,528 cr
- Stock P/E
- 27.9
- Book value
- ₹138
- ROE
- 16.4%
- ROCE
- 20.6%
- Dividend yield
- 0.72%
- 52w high / low
- 583/249
Metrics as of 9 Oct 2026. Not real time.
Track Fermenta Biotech Ltd
Cruxal reads every Fermenta Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Fermenta Biotech Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 7%
- 3 Years
- 14%
- TTM
- -3%
- 10 Years
- 51%
- 5 Years
- 7%
- 3 Years
- 65%
- TTM
- -48%
- 10 Years
- 22%
- 5 Years
- 11%
- 3 Years
- 49%
- 1 Year
- 73%
- 10 Years
- 13%
- 5 Years
- 7%
- 3 Years
- 13%
- Last Year
- 16%
Fermenta Biotech Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹122 cr, down 10.6% from ₹136 cr a year earlier. Net profit was ₹9.53 cr, down 55.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 95.03 | 156 | 140 | 136 | 130 | 137 | 122 | 122 |
| Expenses | 76.25 | 103 | 103 | 108 | 104 | 112 | 102 | 104 |
| Operating profit | 18.78 | 53.27 | 36.95 | 28.24 | 26.64 | 24.96 | 20 | 18.06 |
| OPM % | 19.76% | 34.04% | 26.42% | 20.73% | 20.46% | 18.17% | 16.45% | 14.83% |
| Other income | 2.88 | 2.23 | 3.89 | 8.77 | 5.43 | 0.92 | 14.14 | 4.37 |
| Interest | 3.69 | 4.08 | 2.99 | 3.11 | 2.58 | 3.03 | 2.82 | 2.54 |
| Depreciation | 6.15 | 6.08 | 5.86 | 5.81 | 5.41 | 5.37 | 5.11 | 5.2 |
| Profit before tax | 11.82 | 45.34 | 31.99 | 28.09 | 24.08 | 17.48 | 26.21 | 14.69 |
| Tax % | 5.92% | 16.43% | -4.19% | 23.07% | 25.17% | 31.24% | 29.03% | 35.13% |
| Net profit | 11.12 | 37.89 | 33.32 | 21.6 | 18.03 | 12.02 | 18.6 | 9.53 |
| EPS (₹) | 3.87 | 12.54 | 11.68 | 7.42 | 6.14 | 4.31 | 6.52 | 3.31 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fermenta Biotech Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 164 | 302 | 403 | 292 | 376 | 397 | 349 | 335 | 468 | 523 | 511 |
| Operating profit | 12 | 93 | 156 | 66 | 83 | 62 | 18 | 28 | 115 | 101 | 90 |
| OPM % | 7% | 31% | 39% | 23% | 22% | 16% | 5% | 8% | 25% | 19% | 18% |
| Net profit | -9 | 46 | 117 | 60 | 43 | 15 | -53 | -24 | 76 | 70 | 58 |
| EPS (₹) | -4.14 | 12.21 | 42.71 | 20.23 | 15.46 | 5.25 | -17.36 | -7.84 | 26.12 | 24.39 | 20.28 |
TTM is the trailing twelve months to the most recent quarter.
Fermenta Biotech Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 5 | 14 | 14 | 14 | 14 | 14 | 15 | 14 |
| Reserves | 142 | 122 | 246 | 295 | 346 | 358 | 301 | 274 | 348 | 392 |
| Borrowings | 87 | 173 | 209 | 224 | 232 | 239 | 220 | 139 | 115 | 113 |
| Other liabilities | 75 | 87 | 92 | 80 | 94 | 96 | 102 | 120 | 137 | 128 |
| Total liabilities | 307 | 385 | 551 | 614 | 687 | 707 | 637 | 548 | 614 | 648 |
| Fixed assets | 172 | 177 | 178 | 200 | 263 | 299 | 267 | 269 | 227 | 220 |
| CWIP | 5 | 4 | 22 | 71 | 57 | 35 | 45 | 2 | 16 | 13 |
| Investments | 18 | 10 | 8 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Other assets | 112 | 193 | 344 | 342 | 367 | 373 | 321 | 277 | 372 | 414 |
| Total assets | 307 | 385 | 551 | 614 | 687 | 707 | 637 | 548 | 614 | 648 |
As reported by the company. Total assets equal total liabilities by construction.
Fermenta Biotech Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2 | 59 | 90 | 34 | 63 | 43 | 116 | 105 | 41 | 93 |
| Cash from investing | 7 | -101 | -97 | -44 | -41 | -26 | -55 | -16 | -0 | -43 |
| Cash from financing | -12 | 89 | 12 | -47 | -1 | -22 | -41 | -91 | -51 | -42 |
| Net cash flow | -4 | 47 | 6 | -57 | 21 | -4 | 19 | -1 | -10 | 8 |
| Free cash flow | -17 | 42 | 55 | -34 | 7 | 6 | 76 | 86 | 38 | 63 |
| CFO / operating profit | 35% | 83% | 79% | 73% | 92% | 85% | 610% | 370% | 38% | 108% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Fermenta Biotech Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 2% | 31% | 41% | 12% | 13% | 7% | -0% | 3% | 23% | 21% |
| Debtor days | 99 | 83 | 59 | 87 | 66 | 80 | 44 | 76 | 74 | 78 |
| Inventory days | 208 | 234 | 347 | 594 | 441 | 380 | 309 | 245 | 285 | 290 |
| Days payable | 147 | 183 | 169 | 260 | 169 | 154 | 109 | 182 | 178 | 147 |
| Cash conversion cycle | 160 | 134 | 237 | 421 | 338 | 306 | 244 | 139 | 181 | 221 |
| Working capital days | 33 | 54 | 43 | 70 | 54 | 67 | -18 | 9 | 40 | 96 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Fermenta Biotech Ltd shareholding pattern
Promoters held 64.09% at Aug 2026, broadly unchanged since Sep 2025. FIIs 0.37% and DIIs 0.04%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.06% | 64.08% | 64.08% | 64.08% | 64.08% | 64.08% | 64.08% | 64.09% |
| FIIs | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.13% | 0.37% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.04% | 0.04% |
| Public | 36.98% | 35.00% | 35.00% | 34.75% | 33.99% | 33.32% | 33.19% | 32.95% |
| No. of shareholders | 12,922 | 12,930 | 12,845 | 13,760 | 14,139 | 13,661 | 14,131 | 14,777 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When does Fermenta Biotech Ltd’s board next meet?
Fermenta Biotech Ltd’s board meets on 14 Oct 2026.
- Board meetingInvestor meeting with multiple investors
See the full results calendar for every Indian company reporting in the next 30 days.
Fermenta Biotech Ltd corporate filings
- Fermenta Biotech to hold investor meeting on October 14, 2026Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd, a small-cap company with a market cap of approximately 1,675 crore…
Read the full analysis - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.Company Updatelow impact
- Fermenta Biotech to hold investor meeting on October 07, 2026Company Updatelow impact
Cruxal's analysis: The company has intimated an investor meeting scheduled for October 07, 2026. No…
Read the full analysis - Promoter of Fermenta Biotech Limited sells 3.96% stake in open market on September 28, 2026Insider Trading / SASTmedium impact
Cruxal's analysis: Fermenta Biotech Limited's promoter, Ms. Preeti Thakkar, divested 11,65,938 equity…
Read the full analysis - Intimation of investor meeting to be held on October 5, 2026.Company Updatelow impact
- Intimation of Closure of Trading Window.Insider Trading / SASTlow impact
- Fermenta Biotech Ltd announces intimation of investor meetingCompany Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has filed an intimation regarding an upcoming meeting with…
Read the full analysis - Fermenta Biotech Ltd schedules investor meetingCompany Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Fermenta Biotech Ltd schedules investor meeting for September 17, 2026Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding an upcoming investor meeting…
Read the full analysis - Fermenta Biotech Ltd issues notice for transfer of unclaimed shares to IEPFCompany Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has published a newspaper notice regarding the mandatory transfer of…
Read the full analysis - Fermenta Biotech Ltd initiates transfer of unclaimed shares to IEPFCompany Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has dispatched letters to shareholders regarding the mandatory…
Read the full analysis - Fermenta Biotech signs exclusive license agreement with VIT for Vitamin B12 fortification technologyCompany Updatemedium impact
Cruxal's analysis: Fermenta Biotech has entered into an exclusive license agreement with the Vellore…
Read the full analysis - Fermenta Biotech Ltd schedules investor meeting for September 3, 2026Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding an investor meeting scheduled to…
Read the full analysis - Fermenta Biotech Ltd announces newspaper publication for physical securities dematerializationCompany Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has submitted a newspaper publication regarding a special window for…
Read the full analysis - Fermenta Biotech Ltd schedules investor meeting for August 21, 2026Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding an investor meeting scheduled to…
Read the full analysis - Fermenta Biotech Limited receives credit rating upgrade to CARE BBB+; StableCompany Updatemedium impact
Cruxal's analysis: Fermenta Biotech Limited has received a credit rating upgrade from CARE Ratings, with…
Read the full analysis - Fermenta Biotech Limited reports significant YoY decline in Q1 FY2027 financial performanceCompany Updatehigh impact
Cruxal's analysis: Fermenta Biotech Limited reported a sharp decline in consolidated financial performance…
Read the full analysis - Fermenta Biotech Limited declares dividend of INR 3.75 per share following 74th AGM approvalAGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting…
Read the full analysis - Fermenta Biotech Limited Announces Successful Conclusion of 74th AGM and Shareholder Approval of DividendAGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting held…
Read the full analysis - Fermenta Biotech Limited concludes 74th AGM; approves dividend of INR 3.75 per share and material related party transactionsAGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.